Gb002, Inc.

This Phase 3 study tested whether an inhaled drug called seralutinib could help adults with pulmonary arterial hypertension (PAH), a serious condition affecting blood vessels in the lungs and heart. The main goal was to see if the drug improved patients' ability to walk and delay…